
Haemonetics Corporation HAE
$ 59.16
-1.0%
Quarterly report 2025-Q4
added 02-05-2026
Haemonetics Corporation Total Inventories 2011-2026 | HAE
Annual Total Inventories Haemonetics Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 365 M | 317 M | 259 M | 293 M | 323 M | 270 M | 194 M | 161 M | 177 M | 187 M | 211 M | 198 M | 184 M | 117 M | 84.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 365 M | 84.4 M | 223 M |
Quarterly Total Inventories Haemonetics Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 321 M | 336 M | 361 M | 365 M | 360 M | 382 M | 374 M | 317 M | 304 M | 286 M | 289 M | 259 M | 256 M | 255 M | 278 M | 293 M | - | 323 M | 326 M | 323 M | 300 M | 305 M | 295 M | 270 M | 254 M | 245 M | 222 M | 194 M | 169 M | 164 M | 175 M | 161 M | 159 M | 169 M | 174 M | 177 M | 188 M | 195 M | 189 M | 187 M | 204 M | 208 M | 211 M | 211 M | 212 M | 209 M | 207 M | 198 M | 209 M | 205 M | 197 M | 184 M | 180 M | 174 M | 127 M | 117 M | 108 M | 101 M | 95 M | 84.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 382 M | 84.4 M | 231 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | $ 10.97 | -2.14 % | $ 26.6 M | ||
|
ICU Medical
ICUI
|
616 M | $ 116.64 | -3.61 % | $ 2.87 B | ||
|
The Cooper Companies
COO
|
846 M | $ 61.98 | -1.76 % | $ 12.3 B | ||
|
Microbot Medical
MBOT
|
584 K | $ 2.08 | -1.19 % | $ 95.2 M | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.32 | -2.82 % | $ 26.3 M | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 122.49 | -2.35 % | $ 3.92 B | ||
|
electroCore
ECOR
|
1.63 M | $ 6.26 | 1.79 % | $ 53.1 K | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 4.01 | -1.84 % | $ 185 M | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 21.04 | -3.62 % | $ 1.42 B | ||
|
Isoray
ISR
|
980 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 451.08 | -3.33 % | $ 161 B | ||
|
Glaukos Corporation
GKOS
|
42 M | $ 116.64 | -2.55 % | $ 5.65 B | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 26.0 | -2.64 % | $ 1.29 B | ||
|
STERIS plc
STE
|
581 M | $ 212.66 | -3.39 % | $ 21 B | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 135.05 | -0.34 % | $ 6.03 B | ||
|
Masimo Corporation
MASI
|
459 M | $ 178.56 | 0.03 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
4.82 M | $ 9.85 | -3.24 % | $ 203 M | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 64.8 | -2.91 % | $ 3.83 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 66.14 | -0.71 % | $ 214 M | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 295.56 | 1.22 % | $ 21.4 B | ||
|
Envista Holdings Corporation
NVST
|
288 M | $ 26.23 | -1.02 % | $ 4.41 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 11.47 | -2.67 % | $ 2.29 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.62 | -0.46 % | $ 18.6 M | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 50.62 | -1.73 % | $ 166 M | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | $ 110.54 | -1.65 % | $ 2.5 B | ||
|
Predictive Oncology
POAI
|
481 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
29 M | $ 20.58 | -1.54 % | $ 948 M | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.79 | -4.29 % | $ 163 M | ||
|
Baxter International
BAX
|
2.23 B | $ 17.18 | -4.32 % | $ 8.81 B | ||
|
ResMed
RMD
|
744 M | $ 212.53 | -2.05 % | $ 31 B | ||
|
AtriCure
ATRC
|
78.5 M | $ 27.5 | -3.44 % | $ 1.31 B | ||
|
Harvard Bioscience
HBIO
|
20.8 M | $ 6.27 | -2.79 % | $ 278 M | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
62 M | $ 10.63 | -3.19 % | $ 434 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 145.61 | -2.6 % | $ 41.9 B | ||
|
Nephros
NEPH
|
2.47 M | $ 3.25 | -2.11 % | $ 33.8 M | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 2.97 | -1.33 % | $ 218 M | ||
|
Repligen Corporation
RGEN
|
202 M | $ 113.92 | -2.99 % | $ 6.35 M |